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Abstract
Neuroblastoma (NB) is one of the most deadly solid tumors of the young child, for which
new efficient and targeted therapies are strongly needed. The CXCR4/CXCR7/CXCL12
chemokine axis has been involved in the progression and organ-specific dissemination of
various cancers. In NB, CXCR4 expression was shown to be associated to highly aggres-
sive undifferentiated tumors, while CXCR7 expression was detected in more differentiated
and mature neuroblastic tumors. As investigated in vivo, using an orthotopic model of tumor
cell implantation of chemokine receptor-overexpressing NB cells (IGR-NB8), the CXCR4/
CXCR7/CXCL12 axis was shown to regulate NB primary and secondary growth, although
without any apparent influence on organ selective metastasis. In the present study, we ad-
dressed the selective role of CXCR4 and CXCR7 receptors in the homing phase of meta-
static dissemination using an intravenous model of tumor cell implantation. Tail vein
injection into NOD-scid-gammamice of transduced IGR-NB8 cells overexpressing CXCR4,
CXCR7, or both receptors revealed that all transduced cell variants preferentially invaded
the adrenal gland and typical NB metastatic target organs, such as the liver and the bone
marrow. However, CXCR4 expression favored NB cell dissemination to the liver and the
lungs, while CXCR7 was able to strongly promote NB cell homing to the adrenal gland and
the liver. Finally, coexpression of CXCR4 and CXCR7 receptors significantly and selectively
increased NB dissemination toward the bone marrow. In conclusion, CXCR4 and CXCR7
receptors may be involved in a complex and organ-dependent control of NB growth and se-
lective homing, making these receptors and their inhibitors potential new therapeutic
targets.
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Introduction
Neuroblastoma (NB) is a typical pediatric neoplasm derived from embryonic neural crest cells.
The tumor recapitulates characteristics of its originating cells, with an extensive heterogeneity.
As a consequence, the disease displays a remarkable clinical diversity, ranging from spontane-
ous regression or maturation in response to limited treatment, to fatal progression and dissem-
ination to privileged sites, such as bone marrow (BM), bone, lymph nodes and liver, and to the
lungs although infrequently [1,2]. As with most cancers, NB progression is extremely difficult
to control once disseminated. Residual disease, essentially in the bone and BM, will eventually
relapse and progress, despite high doses and multi-modal therapies [3]. Therefore, better un-
derstanding of the metastatic process and identification of new therapeutic targets to fight the
metastatic disease are strongly needed.
Chemokines and their receptors have been originally described as essential mediators of leu-
kocyte directional migration, and have further emerged as crucial players in all stages of tumor
development [4–8]. CXCR4 was described as the most frequently expressed chemokine recep-
tor on tumor cells [9]. As a result of binding to its unique chemokine ligand, CXCL12, CXCR4
is known to activate G protein-mediated signaling cascades, leading to tumor proliferation,
survival, angiogenesis, and chemotaxis in multiple cancers [8,10,11]. CXCL12 is expressed at
significantly higher level in murine adrenal glands, compared to BM, liver and lungs, while
CXCL12 expression is barely detectable in kidney and heart [12,13]. A role for CXCR4 in medi-
ating secondary growth and preferential homing, in response to CXCL12 released by metastatic
target organs, remains unclear and controversial [10,14–20]. In particular, we have previously
shown in an orthotopic NB xenograft model [21], that CXCR4 mostly promoted NB primary
and secondary tumor growth, without influencing organ-specific dissemination of malignant
NB cells [13].
CXCR7, an alternate receptor for CXCL12, has been subsequently identified next to CXCR4
and was shown to elicit significant distinct functions and a stronger affinity for CXCL12
[22,23]. Ligand binding to CXCR7 does not mediate CXCR4-like, classical G protein-coupled
receptor-mediated calcium mobilization [22–25], but alternative signaling pathways regulating
tumor growth and dissemination [26,27]. Thus, contribution of CXCR7 within tumor environ-
ment has introduced a new level of complexity to CXCL12 signaling. A role for CXCR7, alone
or in association with CXCR4 has been proposed in various solid tumors, including breast, gli-
oma, lung, and prostate cancers [26,27]. Elevated levels of CXCR7 have been detected, particu-
larly in the tumor endothelial cell-associated vasculature [10,28,29]. CXCR7 was also shown to
potentiate and regulate trans-endothelial migration of circulating CXCR4+CXCR7+-tumor
cells, thus leading to enhanced extravasation [30,31]. Thus, CXCR7 is suspected to be involved
in the regulation of organ-specific metastasis [10,28,32]. However, co-expression of the two
CXCL12 receptors may result in the inhibition of invasive properties in response to CXCL12
both in vitro and in vivo [33], suggesting a possible competing cross-talk between CXCR4 and
CXCR7 during metastatic dissemination and homing [30,31].
There is currently very little knowledge on the CXCR4/CXCR7/CXCL12 axis involvement
in human NB progression. A previous report described CXCR7 expression in some NB cell
lines, and a possible in vitro CXCR7-mediated NB migration in presence of CXCL12 produced
by mesenchymal cells [34]. Other reports revealed that CXCR4 and CXCR7 expression pat-
terns on NB tumors are distinct or even opposed, as scarce and preferential expression of
CXCR7 was observed in neural-associated compartment of differentiated and matured tumors
[35], while CXCR4 expression was associated to highly aggressive, undifferentiated tumors
[13,36]. Interestingly, aggressive tumors and metastatic NB cell lines were shown to express
both CXCR4/CXCR7 [34]. In vivo studies performed by implantation of transduced NB cell
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lines expressing CXCR7, CXCR4, or a combination of both receptors, either subcutaneously
or directly in adrenal gland (AG), showed that in contrast to CXCR4, CXCR7 elicited anti-
tumorigenic properties, particularly in presence of CXCR4 [35].
These results witnessed a putative CXCL12 receptors cross-talk in NB cell lines, and sug-
gested the implication of the global CXCR7/CXCR4/CXCL12 axis in the regulation of NB pro-
gression. However, these studies did not reveal an influence of any CXCL12 receptor on organ-
specific metastatic dissemination, particularly in NB preferred sites (such as liver, and bone
marrow) [13,35]. Thus the control of NB progression and organ-specific dissemination by the
CXCR4/CXCR7/CXCL12 axis remains to be clarified.
In this report we focused our investigations in the particular homing phase of NB cells meta-
static dissemination, where the involvement of CXCR4 and CXCR7 receptors was specifically
investigated. Thus, we developed an in vivo intravenous injection model (iv model), allowing
evaluation of site-specific tumor cells seeding, while avoiding initial steps of the metastatic
process, such as primary tumor cell detachment and intravasation. By tail vein injection of
CXCR4- or/and CXCR7-overexpressing IGR-NB8 cells in immunodeficient NOD-scid-gamma
(NSG) mice, we essentially demonstrated that CXCR4 and CXCR7 receptors do influence NB
cell homing, but in a complex and organ-specific way. Indeed, CXCR4 preferentially favors NB
cell implantation in the liver and the lungs, while CXCR7 enhances seeding to the liver and the
AG, and both receptors increase BM invasion.
Materials and Methods
Ethics statement
All in vivo procedures were performed under the guidelines of the Swiss Animal Protection Or-
dinance and the Animal Experimentation Ordinance of the Swiss Federal Veterinary Office
(FVO). Animal experimentation protocols were approved by the Swiss FVO (authorization
number: 1564.6). All reasonable efforts were made to ameliorate suffering, including anesthesia
for painful procedures.
Cell lines
The previously described transduced variants of the human IGR-NB8 cell line [35,37], stably
overexpressing individual CXCR4 (NB8x4), CXCR7 (NB8x7), a combination of both receptors
(NB8x4x7), or control cells (NB8pMigr) were used in this study. Transduced GFP-expressing
cells were sorted by FACS Aria cell sorter (BD Biosciences, San Jose, CA, USA) and cultivated
as whole cell populations [35,37]. The NB8x4, NB8x7, NB8x4x7 and NB8pMigr transduced
cell lines were cultured in Dubelcco’s modified Eagle’s medium (DMEM) (Gibco, Paisley, UK)
supplemented with 1% penicillin/streptomycin (Gibco) and 10% heat inactivated Foetal Bovine
Serum (FBS) (Sigma-Aldrich, St Louis, MO, USA). HUVECs were obtained from Lonza
(Walkersville, MD, USA), and were cultured on 0.5% gelatin-coated flasks in EGM-2 Medium
(EGM-2 Bullet Kit, Lonza, Cologne, Germany) up to passage 7.
Flow cytometry
Single cells were stained with mouse anti-CXCR4 (clone 12G5, BD Biosciences), or mouse
anti-CXCR7 (clone 11G8, R&D systems) antibodies, as previously described [13]. Alexa Fluor
647-labeled goat anti-mouse was used as secondary antibody (Invitrogen, Carlsbad, CA, USA).
Ten thousand events were analyzed by Gallios cytometer (Beckman Coulter).
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Adhesion assay
HUVECs were allowed to attach in a 24-well plate (Costar), preliminary coated with 0.5% gela-
tin (Sigma-Aldrich, St Louis, MO, USA), in EGM-2 Medium (Lonza) at 37°C until confluence.
EGFP-expressing NB cells, preliminary starved in serum free medium (SFM) for 12h, were
harvested with PBS-5mM EDTA, and wash with PBS. Then, 105 NB cells were seeded on
HUVEC monolayer in SFM, in presence or in absence of 100ng/ml CXCL12 (PeproTech,
Rocky Hill, NJ, USA) for 1h at 37°C. After two brief wash with PBS, eGFP fluorescence in each
well was read using a plate reader (λExcitation 485 nm; λEmission: 515 nm). EGFP fluorescence of
HUVECs in absence of NB cells was measured as control. Number of adherent NB cells was
then assessed according to a standard curve method. Five independent experiments were con-
ducted in triplicates.
Invasion assay
Growth factor-reduced Matrigel (BD Biosciences), diluted at 3 mg/ml in serum free-DMEM
(SFM) and supplemented with 1% N2 supplement (Gibco) (N2-SFM), was gently spread across
the entire surface of 8μm porosity-polycarbonate filters of Costar cell culture inserts (24-well
format, BD Biosciences). Matrigel was then allowed to solidify for 2h at 37°C. NB cells (5×104),
starved in SFM for 12h, were suspended in 100 μl N2-SFM, and seeded in the upper compart-
ment of the insert. The lower compartment was filled with N2-SFM, in presence or in absence
of 100 ng/ml CXCL12 (PeproTech). After 48h incubation at 37°C, Matrigel and medium from
both upper and lower chambers were carefully removed. Membranes were washed with PBS,
and fixed for 10 min in 4% paraformaldehyde (PFA) (Fluka, Buchs, Switzerland). Non-invasive
cells were carefully scraped from the upper side of the filter. Membranes were then stained
with DAPI, and invasive cells on the lower side were counted in one 10x magnification field
per condition using fluorescent microscopy (Leica Microsystems Schweiz AG, Switzerland).
Imaging was performed using a camera DFC345 FX (Leica Microsystems Schweiz AG, Switzer-
land). Three independent experiments were conducted in triplicates.
Intravenous injection in mice
All animal experiments were carried out with NOD-scid-gamma (NSG) mice from the Jackson
Laboratory (UK). All in vivo procedures were performed under the guidelines of the Swiss Ani-
malProtection Ordinance and the Animal Experimentation Ordinance of the Swiss Federal
Veterinary Office (FVO). Animal experimentation protocols were approved by the Swiss FVO
(authorization number: 1564.6). All reasonable efforts were made to ameliorate suffering, in-
cluding anesthesia for tumor cell injections. Transduced IGR-NB8 cells were detached in 5mM
PBS-EDTA, 2×106 cells were suspended in 200 μl serum-free DMEM, and injected in the tail
vein of 5 to 6 seven-week old mice using a 29G insulin syringes (BD Biosciences). After tumor
cell implantations, mice were checked twice a week for their physical conditions, activity, and
posture, as well as by palpation for tumor detection. Humane endpoints were in place for early
euthanasia base on these observations. One mouse met these criteria 6 weeks after implanta-
tion, so all mice were sacrificed at this time point. Two weeks and 6 weeks post iv injection,
mice were anesthetized by isoflurane gas inhalation, euthanized by cervical dislocation accord-
ing to standard guidelines, and then quickly perfused with PBS by intracardiac injection. Mice
numbers per group are at W2 n = 6 for NB8pMigr, n = 4 for NB8x4, n = 5 for NB8x7, and
NB8x4x7, while at W6 n = 5 for all mice groups. Pieces of liver, lung, adrenal gland, heart and
kidneys were either snap-frozen in liquid nitrogen and kept at -80°C until RNA extraction, or
formalin-fixed for 12h before processing, and paraffin-embedding.
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Bone Marrow extraction
At sacrifice, femurs and tibias of NSG mice were cut with scissors, and muscles were rubbed
off. BM was then flushed out with PBS using a 25G needle. After 10 min centrifugation at
10’000 rpm, BM was fully disaggregated in PBS using a 19G needle. Erythrocytes were lysed
using Red Blood Cell Lysis Buffer (Biolegend) for 10 min at 37°C. BM was washed two times in
PBS, and dry pellet was kept at -80°C until RNA extraction.
Total RNA extraction
Total RNA from cell lines and mouse BM were extracted using the RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to manufacturer’s instructions. For total RNA extraction from
murine organs, 30–50 mg pieces of snap-frozen tissues were disrupted and homogenized in
TRIzol Reagent (Invitrogen) for up to 15s using a Polytron PT 1200E (BLANC-LABO, Switzer-
land). Total RNA was then extracted using the miRNeasy Mini Kit (Qiagen) according to
manufacturer’s instructions.
Semi-quantitative real-time PCR
Total RNA was reverse-transcribed using PrimeScript RT reagent Kit, according to the manu-
facturer’s instructions (TAKARA Bio Inc., Shiga, Japan). Semi-quantitative real-time PCR was
performed using Corbett Rotor-Gene 6000 (Qiagen) with QuantiFast SYBR Green PCR Kit
(Qiagen) to analyze eGFP expression levels using primer specific for eGFP: fw 5’- ACT ACC
AGC AGA ACA CCC C -3’ and rev 5’- TCA CGA ACT CCA GCA GGA C -3’. Cycling condi-
tion were 5min at 95°C, 40 cycles of 10s at 95°C, 30s at 60°C, 1s at 72°C. EGFP expression levels
in mouse tissues were assessed according to the standard curve method.
Immunohistochemistry
Hematoxylin and eosin (H&E) and IHC stainings were performed at the Mouse Pathology Fa-
cility of Lausanne University (Epalinges, Switzerland). IHC labeling was performed using the
mouse monoclonal anti-human vimentin Ab (clone RV202, GeneTex, CA, USA), anti-Ki67
(clone MIB-1, Dako, Denmark), and anti-cleaved caspase-3 (ASP175)(#9661, Cell Signaling
Technology Inc.) on 4 μm-thick paraffin-embedded mouse tissue sections.
Statistical analyses
Statistical analyses were performed using GraphPadPrism 6.0 (GraphPad Software Inc., San
Diego, CA, USA). p<0.05 represented significance; p0.01 and p0.001 were inter-
preted to be highly significant.
Results
CXCR4 and CXCR7 receptors impact on in vitro invasion capacity of NB
cells
To investigate the respective role of CXCR4 and CXCR7 receptors on the homing and invasive
phases of the metastatic process, we used transduced variants of the human IGR-NB8 cell line,
mock transfected (NB8pMigr) or stably overexpressing individual CXCR4 (NB8x4), CXCR7
(NB8x7), or a combination of both receptors (NB8x4x7), described previously [35] (Fig 1A).
The ability of these transduced NB cells to adhere on endothelial cells (HUVEC) was first
analyzed in vitro. Neither CXCR4 nor CXCR7 were capable to influence NB cells adhesion
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Fig 1. CXCR4 and CXCR7 receptors modulate invasive, but not adhesive properties of transduced NB cells in vitro. A. CXCR4 and CXCR7 cell
surface expression in the NB8 transduced cell lines. CXCR4, CXCR7 or a combination of both CXCL12 receptors was overexpressed in the IGR-NB8 cell
line by retroviral infection. NB8pMigr cell line represents control cells transduced with the pMigr empty vector. Percent of CXCR4 (blue) and CXCR7 (green)
positive transduced cells are indicated. Grey histogram: cells stained without primary antibodies; blue and green histograms: cells stained with anti-CXCR4
and anti-CXCR7, respectively. B. Adhesion capacities of NB8x4, NB8x7, NB8x4x7, and the mock transduced NB8pMigr control cell lines on HUVEC
monolayer in vitro. Mean ± SD of the ratio of adherent NB cell number relative to that of NB8pMigr control cells are plotted in the graph. Five independent
experiments were conducted in triplicates.C. Invasive capacities of transduced NB8 cells toward CXCL12 through Matrigel. Mean ratio ± SD of the number of
invasive cells in presence versus in absence of CXCL12 are plotted in the bare graph. Three independent experiments were conducted in triplicates. Multiple
comparisons were performed using the parametric one way Anova test with Bonferroni corrections: *p<0.05, ***p<0.0005.
doi:10.1371/journal.pone.0125616.g001
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capacities on HUVECs when overexpressed in the IGR-NB8 cell line, both in absence (Fig 1B)
or in presence of CXCL12 (data not shown).
We next investigated whether in vitro invasive properties of NB cells were modified by the
expression of any of the two CXCL12 receptors. Overexpression of CXCR4 alone resulted in a
significant increase of the in vitro invasive potential of NB8x4 cells toward the chemokine
CXCL12, relative to NB8pMigr control cells (Fig 1C). In contrast, exogenous expression of
CXCR7 had no effect on NB8 invasive property. Interestingly, the invasive capacity of
NB8x4x7 cells was enhanced relative to NB8x7 cells, but was reduced when compared to
NB8x4 cells (Fig 1C), highlighting a crosstalk between both CXCL12 receptors in vitro.
CXCR4 and CXCR7 receptors are involved in site-specific homing of
circulating NB cells
To focus our study in the specific homing phase of metastatic process, we developed an in vivo
tail vein injection model allowing evaluation of site-specific metastatic seeding of tumor cells,
while avoiding tumor cells exit from their primary site of growth. Thus, to investigate whether
expression of any one of the two CXCL12 receptors or both in NB tumor cells could influence
their selective homing, eGFP+ transduced IGR-NB8 control cells or cell lines overexpressing ei-
ther CXCR4, CXCR7, or combined receptors, were injected iv in NSG mice. Mice were sacri-
ficed 2 weeks (W2) and 6 weeks (W6) after iv injections for investigation of specific organ
invasion patterns of tumor cells, and for tumor growth evaluation.
At W2, no macroscopic metastases could be observed at dissection after detailed examina-
tion of mice. Microscopic dissemination patterns of transduced eGFP+-IGR-NB8 cell lines in
liver, AG, BM, lungs, kidney, and heart were first measured by real-time PCR for the detection
of eGFP mRNA expression. These analyses revealed significant eGFP signals in the AG, the
BM and the liver derived from all transduced IGR-NB8 cells (Fig 2 and data not shown). In
contrast, a very weak eGFP signal was measured in the kidney and the lungs of mice injected
with all transduced cell lines (Fig 2 and data not shown). No eGFP expression was detected in
the heart of mice injected with control or CXCL12-receptor expressing cells (Fig 2), indicating
that, at W2, circulating NB cells do not invade such organ, even in presence of chemokine re-
ceptors. In addition, these investigations revealed that IGR-NB8 cells overexpressing CXCR7
(NB8x7) displayed an enhanced capacity to invade AG, when compared to NB8pMigr control
cells (Fig 2), suggesting that specific homing to the AG could be mediated by CXCR7 expres-
sion. Moreover, while neither CXCR4 nor CXCR7 displayed any significant effect on NB cell
homing to the BM, a strongly enhanced eGFP signal was observed in the BM of NB8x4x7
group of mice (Fig 2), suggesting a positive effect of the coexpression of CXCR4 and CXCR7 re-
ceptors on NB cell dissemination to the BM.
In contrast to BM and AG organs where the eGFP expression analysis concerned the totality
of the organ, only representative samples of larger organs, such as liver and lungs, could be ana-
lyzed by real-time PCR. Therefore, for more complete and precise examination of micrometas-
tases dissemination patterns in those organs, large tissue sections were examined by IHC. Anti-
human vimentin labeling was selected as it gave strong and highly specific signals in NB tu-
mors, as shown in orthotopic NB tumors derived from all transduced IGR-NB8 cells [35],
while normal murine tissues were negative (Fig 3A). At W2, anti-vimentin IHC staining re-
vealed that the number of hepatic micrometastases detected in NB8x4, NB8x7, and NB8x4x7
groups was increased as compared to the control NB8pMigr group (Fig 3B and 3C), suggesting
that both CXCL12 receptors are involved in NB cell homing to the liver.
Although the lungs do not represent a common metastatic site in NB, they may also be in-
volved and were thus investigated. At W2, almost no metastatic NB cells could be detected by
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vimentin IHC (Fig 3D), which is in accordance with the very low eGFP signal detected by
real-time PCR (data not shown). Thus, micrometastases dissemination in the lungs was fur-
ther explored at W6 by IHC, which revealed the presence of numerous microscopic metasta-
ses or single NB cells at this time point (Fig 3E and 3F). These data indicate a delay in the
occurrence and growth of micrometastases in the lungs compared to the AG, the BM and the
liver. Although not statistically significant due to the weak mice number (p = 0.413 for NB8x4
and p = 0.056 for NB8x4x7), the amount of vimentin-positive micrometastases in lungs is in-
creased in the NB8x4 and NB8x4x7 groups as compared to NB8pMigr control group (Fig 3F),
suggesting a potential role for the CXCR4 receptor in NB cell dissemination into the lungs.
Surprisingly a weak decrease in metastatic numbers was observed in the NB8x7 group com-
pared to NB8pMigr group, suggesting that CXCR7 might not favor NB cell homing to the
lungs (Fig 3F).
Fig 2. Organ-specific involvement of CXCR7 and CXCR4 in NB cell homing. Analyses of microscopic
metastases derived from iv injection of NB8pMigr, NB8x4, NB8x7, and NB8x4x7 cells in NSGmice. eGFP
mRNA expression levels measured by semi-quantitative real-time PCR analyses in adrenal gland (AG), bone
marrow (BM), kidney, and heart of all mice per groups at week 2 post injection. At least two independent
qPCR analyses were conducted per organ and per mouse. Individual values, and mean values ± SD of eGFP
mRNA expression levels detected in transduced NB8 cell lines are plotted in individual graphs for each organ
(Mann-Whitney test **p<0.01).
doi:10.1371/journal.pone.0125616.g002
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Fig 3. CXCR7 and CXCR4 favor site-specific homing of circulating NB cells after iv injection. A. Vimentin IHC staining of paraffin-embedded sections
of orthotopic primary tumors derived from NB8pMigr, NB8x4, NB8x7, and NB8x4x7 cells (magnification 40x) [35], and normal lung and liver tissues from NSG
mice (magnification 10x).B.One representative picture of vimentin IHC staining of liver tissue sections from 4 mice per group at W2 post iv injection
(magnification 4x). C.Graph representing individual numbers, and mean numbers of hepatic metastases per group at W2 ± SD. Tumor foci were counted
under light microscope in two complete liver tissue sections per mouse (MannWhitney test, *p<0.05, **p<0.005).D. Vimentin IHC staining of one
Organ-Specific Involvement of CXCR4 and CXCR7 in NB Cell Homing
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Examination of mice at W6 confirmed the massive invasion of the liver (Fig 4), the bone
marrow and the adrenal glands (data not shown), while the lungs are only involved with micro-
scopic metastases (Fig 3E).
Altogether these results demonstrate that CXCR4 and CXCR7 receptors are both involved
in NB cell homing, however their involvement may vary in an organ-dependent manner.
CXCR4 and CXCR7 receptors enhance metastatic growth in the liver
We next investigated whether and how both CXCL12 receptors influence tumor growth, once
disseminated to target organs. As macroscopic metastases were only observed in the liver at
W6 (Fig 4A), our investigations were focused on this organ. Indeed, livers from mice implanted
with NB8x4, NB8x7, and NB8x4x7 cells displayed numerous macroscopic metastases at W6, in
contrast to the NB8pMigr control group, which did not present any liver macroscopic metasta-
ses (Fig 4A). The detailed analysis of hepatic macrometastases by IHC at W6 confirmed their
strongly increased size in NB8x4, NB8x7, and NB8x4x7 groups, as compared to the NB8pMigr
control group (Fig 4B). Hepatic metastases displayed almost no stroma infiltration. Interesting-
ly, liver metastases derived from NB8x7 cells displayed massive hemorrhage, resulting in the
formation of large blood lake (Fig 4B, black arrows).
Strong Ki67 staining and sporadic cleaved-caspase-3 staining by IHC further revealed an ex-
tremely high proliferation index together with the presence of only rare apoptotic cells in he-
patic metastases of all mice groups (Fig 4C), indicating that hepatic metastases at W6 are
mainly composed of highly proliferative cells. Interestingly, high expression level of CXCL12
was previously observed in the liver in mice [12,13]. Overall, these data suggest an implication
of the CXCR4/CXCR7/CXCL12 axis in hepatic metastases growth induction in such iv model.
Discussion
Our previous in vivo orthotopic studies in NB revealed an essential growth-promoting role for
CXCR4, the long-time known CXCL12 receptor, which could be modulated by co-expression
of CXCR7, the second and more recently identified CXCL12 receptor [35]. Such observations
already indicated a possible cooperation or competition between the two receptors in NB.
However in this orthotopic model, in contrast to several reports in different cancers, including
NB [16], CXCL12 receptors either alone or in combination did not increase metastatic dissemi-
nation nor modified the typical NB metastatic pattern, suggesting that these chemokine recep-
tors may not influence NB metastatic process [13,35]. Nevertheless, in such NB orthotopic
model, the very high level of CXCL12 chemokine present in the adrenals [12,13], may have
mobilized CXCR4/7 receptors-expressing cells, and thus prevented their dissemination.
In this context, we were interested in specifically dissecting CXCR4/CXCR7/CXCL12 axis
involvement in the specific homing phase of metastatic dissemination. As preliminary in vitro
investigations, we observed that adhesive properties of NB cells to HUVEC were not influenced
by expression of any CXCL12 receptors, in presence or in absence of the ligand. These observa-
tions differ from previous studies in other tumor models showing that CXCR7 expression im-
proved tumor cell adhesion on HUVECs in presence, and in absence of chemokine ligands
[22,29,38,39]. In addition, we observed that CXCR4 expression alone significantly enhanced
NB cells in vitro invasive capacity, while CXCR7 alone had no effect, confirming a previous
representative lung tissue sections per group at W2 post injection (magnification 10x). E. Vimentin IHC staining of representative lung tissue sections from
two mice per group at W6 post injection (magnification 20x). F.Graph representing numbers of vimentin positive micrometastases in lungs for each mouse,
and mean numbers per group ± SD at W6 post injection. Vimentin-positive micrometastases were counted in 11 randomly selected fields (magnification 10x)
of one section of paraffin-embedded lung tissue of five mice per group (MannWhitney test, *p<0.05).
doi:10.1371/journal.pone.0125616.g003
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Fig 4. CXCR4 and CXCR7 receptors enhancemetastatic growth in the liver. A. Pictures of one
representative liver of each group at sacrifice (W6). B. Vimentin IHC staining of liver sections of 5 mice per
group at W6.C. Ki67 and cleaved caspase-3 (C3) IHC of one representative hepatic metastasis at W6
(magnifications 10x and 40x). Positive control for cleaved C3 is inserted in the small insert (NB8x4 orthotopic
tumor, magnification 40x).
doi:10.1371/journal.pone.0125616.g004
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report in NB [34]. However, the observed modulation of in vitro CXCR4-mediated invasive
properties by CXCR7, that was not detected in this earlier report [34], further supports an ex-
isting interaction and/or competition between both receptors as previously described in various
cancers [13,30,31,33,35].
To investigate whether and how the CXCR4 and CXCR7 receptors are involved in metastat-
ic cell homing and invasion into specific NB target organs, we worked out an in vivo iv model,
where control and transduced NB cells, expressing either one or both receptors, were im-
planted directly into the circulation of immunodeprived NSG mice. In such conditions, macro-
scopic tumors could only be observed in the liver at W6. Nevertheless, a more sensitive
detection of NB cells in mice organs either by real-time PCR, or by vimentin staining, revealed
the presence of NB cells in different organs. Although in absence of CXCL12 receptors expres-
sion, circulating NB8pMigr control cells preferentially home to the AG, the liver and the BM,
already 2 weeks after NB cells implantation; CXCR4 and/or CXCR7 expression potentiate NB
cell homing in an organ-dependent manner. In all mice groups, no eGFP signal was detected in
the heart, while extremely low eGFP signals were detected in the lungs and the kidneys at W2.
Metastatic dissemination of NB cells in the kidney had been previously described in iv and sub-
cutaneous models of NB, although this organ is not targeted by NB cells in patients [16]. Our
observations thus indicate that NB cells are able to preferentially home and establish in
specific organs.
Interestingly, CXCR4 expression enhanced NB8 cell implantation in the liver and potential-
ly in the lungs, while CXCR7 expression promoted NB cell homing to the AG and the liver.
Moreover, coexpression of CXCR4 and CXCR7 significantly increased NB cell homing to the
BM, while neither CXCR4 nor CXCR7 alone played a significant role in the BM. Such effect re-
sulting from the coexpression of CXCR4 and CXCR7 could not be observed in the other organs
analyzed. Such enhanced tumor cell specific homing in the BMmediated by coexpression of
both CXCR4 and CXCR7 receptors correlate with a previous study reported in a rhabdomyo-
sarcoma model [38].
Thus, CXCR4 and CXCR7 receptors influence NB cell homing and dissemination in a com-
plex and organ-specific manner. The differences in the involvement of CXCR4 and CXCR7 re-
ceptors between in vitro and in vivo NB cell invasion can be explained by the fact that in vivo
invasion results from an environment-dependent multistep process, involving the ability of
tumor cells to arrest in a specific organ, adhere to endothelial cells, extravasate, and establish
an appropriate microenvironment for proliferation. This is the first study reporting an organ-
specific influence of balanced expression of CXCR4 and CXCR7 chemokine receptors in meta-
static dissemination. Indeed, studies in other tumor models revealed either a role for CXCR4,
but not for CXCR7, in metastases induction [40], or the enhanced metastatic potential con-
ferred by CXCR7 [39].
In this iv model, AG, which corresponds to the natural and privileged site for primary NB,
reveals as an early site of invasion, even by CXCR4/7-negative NB8pMigr cells. However,
CXCR7 in contrast to CXCR4 was significantly involved in enhancing AG selective homing.
Interestingly, controlateral AG invasion has not been reported in patients with metastatic NB.
Therefore, CXCR7 is a possible player not only in metastatic homing of NB cells, but also in
other mechanisms controlling NB development in the AG, which deserves to be
further investigated.
In addition, we observed that the lungs were generally involved with only very small micro-
metastases at W6, likely to reflect a less attracting and/or less permissive environment for NB
cells implantation and growth. This is in accordance with the infrequent clinical occurrence of
NB metastatic spread in the lung, which represents late event in widely disseminated metastatic
disease [41,42]. The role of CXCR7 in mediating lungs metastases vary according to cancer
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types [39,43–45]. In this iv NB model, CXCR7 expression faintly reduced the number of lung
metastases. In contrast, although not statistically significant due to heterogeneity and the low
number of mice in this study, CXCR4 receptor (NB8x4 and NB8x4x7) was able to strongly en-
hance the number of lung metastases, supporting a CXCR4 receptor influence on NB cell inva-
sion of the lungs, and a possible involvement of the CXCR4/CXCL12 axis in lungs metastases
occurrence in patient with highly disseminated NB disease.
Examination of murine livers revealed the impact of CXCR4 and CXCR7 receptors both on
the selective homing and on macrometastatic growth induction, as both the number and the
size of liver metastases were strongly increased with cells expressing CXCR4 and/or CXCR7.
Hepatic metastases displayed elevated proliferation index together with rare apoptotic cells in
all groups, confirming that liver is a highly permissive environment for NB cells growth. How-
ever, cells expressing CXCR7 alone (NB8x7 cells) generated highly hemorrhagic liver metasta-
ses with large blood lakes. Such CXCR7-mediated metastatic pattern may result from distinct
and additional mechanisms that need to be further investigated. These data confirm the role of
CXCR4 in promoting growth of primary and secondary tumors as already demonstrated [13].
However, this iv model did not confirm the abrogative effect of CXCR7 on CXCR4-mediated
tumor growth observed in our orthotopic NB model [35]. These somehow contrasting results
may be due to the different models and environments investigated in the orthotopic and
iv models.
Altogether these data demonstrate that in this NB model, CXCR4 and CXCR7 receptors
play a role in organ selective homing and invasion, which depend on the target organ. The
balance in the expression levels of the two CXCL12 receptors reveals their participation into
complex mechanisms controlling metastatic homing and growth, encouraging further investi-
gations into the role of these receptors and tumor environment. These findings also reveal
CXCR7, in addition to CXCR4, as possible targets for new therapeutic strategies against ag-
gressive and metastatic NB disease.
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